Forum vs. Social Media Engagement

Online forums engage users more than many other types of social media. For instance, some 85.3% of all Twitter users post less than one update per day, while 21% haven’t posted any tweets at all, according to Marketwire. Other social media giants, like LinkedIn, aren’t faring much better with 1% of its users accounting for 34% of its traffic by some estimates.

By contrast, most online forums attract a passionate and more engaged user base. For example, CrowdGather has approximately 16 million people registered on their network sites with more than 350 million posts, according to their latest 10-Q filing with the SEC. Moreover, forum users tend to be centered around one niche – such as golf or paintball – making them ideal for advertisers looking for better targeting.

Bridging the Social Monetization Gap

Many Internet stocks are valued by a metric called Average Revenue Per User (ARPU). For example, Facebook had an ARPU of $2.30 in December of 2009, according to a Deloitte study. While ARPU figures are on the rise, they are still much lower than many forms of traditional advertising, which is one of the reasons why companies like LinkedIn aren’t yet profitable.

CrowdGather offers a bridge between these two forms of income. Since online forums drive search traffic, the company generates a high number of page views and can monetize its properties via traditional CPM/CPC advertising. However, its advertising platform is also being fine-tuned to target specific niches and users, which could expand its possibilities.

A Better Alternative to Traditional Social Media

CrowdGather Inc. (OTCBB: CRWG) offers investors a unique opportunity in the social media sector. Its network of online forums offer greater user engagement than traditional social media, while its search engine friendly content gives it more revenue streams than many cash-burning social media giants out there today.

For more information about this company, please see the following links:

• Company Website
• Recent SEC Filings
• Company Profile

Trump Gives Compelling Speeches

Last month, Donald Trump Jr. presented on behalf of MacroSolve at the NYC Small Cap Conference. The executive vice president of The Trump Organization gave a clever and insightful speech that highlighted the growing popularity of mobile and how MacroSolve’s edge makes it the best investment opportunity in the sector today. In addition to the increased publicity that helps set the firm apart from its competition, the agreement also serves as a vote of confidence in the technology itself by The Trump Organization.

In his recent speech, Mr. Trump noted, “[MacroSolve’s] 15-years of experience prove they know how to spot the waves, judge the direction of the wind, and ride the shifting tides in the digital marketplace. MacroSolve has that edge. They have that hunter’s nose. They have a proven track record of pioneering development and a long-established relationship with the top name brands in wireless hardware, software and carriers. Their patent portfolio puts them years ahead in innovation, while their enterprising move to be a publicly traded app company – a rarity in the industry – shows they have positioned themselves to be the next Model-T maker.”

Significant Business Development Potential

Donald Trump Jr. is executive vice president of The Trump Organization, which owns and develops hotels, resorts, residential towers, and gold courses in various countries, as well as owns several high-end real estate locations in New York City. Combined, these various properties and businesses represent significant business development opportunities for MacroSolve that could lead to additional revenues down the road.

In fact, in an October press release, Mr. Trump commented: “Just as in physical real estate – digital real estate is location, location, location. Having a company’s brand and logo on the screen of mobile devices is a valuable place to be for a company looking to drive revenues and productivity. The mobile app market is exploding and is a major part of our Trump branded businesses … With the combination of exploding market demand for mobile apps and the depth of experience and expertise of the management team at MacroSolve, I see unparalleled potential in this agreement.”

Click here for a video of the Corporate Profile report on MacroSolve’s agreement with Donald Trump Jr.

A Great Investment Opportunity

MacroSolve’s agreement with Donald Trump Jr. may be just icing on the cake, but it does expand the company’s presence and set it apart from the competition. Meanwhile, the vote of confidence on the part of The Trump Organization should help reassure investors. And finally, business development opportunities within the organization could unlock further value.

To learn more about MacroSolve, please see the following resources:

• Company Website
• Recent SEC Filings

Gryphon Gold Corporation (TSX: GGN.TO)(OTC.BB:GYPH.OB) is pleased to announce that it has optioned the Castle Peak Property located in Esmeralda County, Nevada from Kinross Gold Corporation. The Castle Peak Property hosts a low sulfidation, epithermal gold system that has encountered up to 90 feet of 0.014 opt gold starting a depth of 30 feet.

Castle Peak is located within the Gilbert-Boss-Castle Mining District in Western Esmeralda County, Nevada and consists of 40 unpatented mining claims (800 acres) located at the southern margin of the Monte Cristo Range. The Property is situated 6.5 miles west of the Seabridge Gold’s Castle-Black Rock Property and is hosted in the same Miocene rhyotite and andesite host rocks with similar low sulfidation alteration.

Kinross has drilled 35 holes at the Castle Peak Property that encountered +0.003 opt gold over at least 20 feet in 23 of the 35 reverse circulation holes. Gold mineralization is hosted in Miocene rhyolite and overlying andesite that has undergone quartz-illite alteration related to sheeted and stockworked quartz veins. Surface rock geochemistry indicates a gold-silver epithermal system in which 93 of 770 samples analyzed contained over 0.029 opt ppm gold with anomalous mercury, arsenic, and antimony.

“The Gilbert-Boss-Castle District hosts alteration over a similar area and of similar intensity to that of the major districts of the Walker Lane to include Goldfield, Tonopah, and the Comstock” says Steve Jones, Gryphon’s VP of Exploration. “Castle Peak with its possible ore grade intercepts is a great place for Gryphon to start its evaluation of a major district.”

Under the option agreement, Gryphon Gold will receive a 100% interest in the Castle Peak Property by expending US$1,000,000 in field expenditures over four years. Kinross will retain a Net Smelter Royalty of 2% if the spot price of gold is less than or equal to US$1,500 per ounce or 3% Net Smelter Royalty is the spot price of gold exceeds US$1,500 per ounce. Kinross has the option of regaining up to 75% control of the Property if Gryphon reports a NI43-101 compliant resource of over 2.0 million ounces of gold and if Kinross expends three times (3x) the expenditures of Gryphon with all expenditures spent on field work on the Property. Kinross will have a 120-day period to exercise its right to earn back its control of the property after the NI43-101 reporting of the +2.0 million ounce resource. Gryphon is not required to make any payments to Kinross and the four-year, $1,000,000 earn-in will be spent entirely on field work on the Property.

All technical information contained in this release has been reviewed and approved by Steven K. Jones, CPG, Vice President Exploration for Gryphon Gold Corporation and a “qualified person” within the meaning of National Instrument 43-101. Steven K. Jones has verified the sampling data referred to in this press release.

(ii) Data sourced from www.seabridgegold.net

ABOUT GRYPHON GOLD:

Gryphon Gold is a Nevada-focused gold exploration company. The Company’s principal property is its Borealis gold project located in the Walker Lane gold belt of western Nevada.

This press release contains “forward-looking statements” and “forward-looking information” within the meaning of United States and Canadian securities laws, which may include, but are not limited to statements relating ; assumptions related to ability to fund the earn in payments required for the Castle Peak Property, capital requirements and exploration; assumptions related to gold grade and recoverability, success of exploration and drill programs and other statements relating to plans, estimates, objectives, and timing. Such forward-looking statements and forward-looking information reflect our current views with respect to future events and are subject to certain risks, uncertainties and assumptions, including, the risk that additional financing for the development of the Castle Peak Property, may be required, and if so, may not be available on terms satisfactory to the Company if at all, risks associated with the start up of mining operations, and the risks and uncertainties outlined under the section headings “Forward-Looking Statements” and “Risks Factors and Uncertainties” in the Company’s annual report on Form 10-K, as filed with the SEC and Canadian securities regulatory authorities on June 30, 2011, and in the Company’s other reports, documents, and registration statements filed with the SEC (available at www.sec.gov) and with Canadian securities administrators (available at www.sedar.com ). Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. The Company does not undertake to update forward-looking statements or forward-looking information, except as may be required by law. Full financial statements and securities filings are available on the Company’s website: www.gryphongold.com and www.sec.gov or www.sedar.com.

Silver Dragon Resources Inc. (OTCBB: SDRG) is a metals and mining company focused on the exploration and development in proven silver districts around the world, similar to companies like Minco Gold Corporation (AMEX: MGH) and Coeur d’Alene Mines Corporation (NYSE: CDE). After releasing its NI 43-101 report in September, the company appears to be significantly undervalued.

Dadi Silver Project Could be Worth $55 Million

Silver Dragon’s flagship Dadi Silver Polymetallic project in Inner Mongolia, China could be worth $55 million in today’s dollars, according to a discounted cash flow analysis. The company’s NI 43-101 report showed a 40 g/t cut-off grade that will generate net cash flows over the seven-year project life of $207 million, of which $82 million will accrue to the company (based on Silver Dragon’s 40% interest in the project). The report then applies an annual discount rate of 8% to arrive at the current net present value of $55 million. It should be noted that Silver Dragon has used a conservative 3-year average market price of $21/oz. for silver, which is only 67% of the current spot price of $31.30/oz (10/6/11).

With a market capitalization of just $5.77 million, the company appears to be significantly undervalued given this potential. A valuation of just $20 million – less than half of the project’s net present value – would equate to a share price of $0.133 per share. And these figures do not include the potential from its many other development properties in China.

Just the Beginning: Other Properties and Up-Listing

Silver Dragon recently provided investors with an update on the rest of its properties and has made application for a dual listing on a Canadian stock exchange. These updates signaled strong progress across all of its properties:

• The Erbahuo Silver Mine – Mining is in progress, with work focusing on tunnel development, however over 3,000 tonnes of silver ore have been mined to date. Construction of the ore processing plant is in progress and near completion, which means investors could see some near-term revenues.

• The Laopandao Silver-Tin-Copper Project is undergoing tunneling and testing, and investors can expect to see an NI 43-101 report to be released later this month.

• The Aobaotugounao Silver-Lead-Zinc project is undergoing drilling and three additional holes have been approved within this year’s exploration plans.

• Field surveys are being conducted on its other properties in Yuanlinzi, Zhuanxinhu and Shididonggou.

A Great Investment Opportunity

Silver Dragon Resources Inc. (OTCBB: SDRG) represents a unique investment opportunity. With just one of its projects showing an NI 43-101-backed $55 million net present value, the stock appears to be significantly undervalued. Meanwhile, its other projects continue to progress towards commercialization and long-term value.

For more information, please see the following resources:

• Company Website
• Company SEC Filings

Key Highlights

• Near-term Revenue Drivers. OurPet’s Company launched new Cosmic Pet and Go Cat Go!!!® lines that included about 150 new SKUs, while its SmartScoop® was also recently re-launched.  Combined, these products are expected to contribute to an increase in net revenues and profit during the second half of 2011.
• Bottom-line Improvements. OurPet’s Company has implemented initiatives to control costs, while scaling its business for anticipated long-term growth.  The company’s new ERP system will also help keep its inventories lean and nimble, while it works to improve its bottom-line to unlock further shareholder value.
• Great Investment Opportunity. OurPet’s Company’s market capitalization is currently less than one time (1x) sales for the past 12 months.  Based on strong top line growth, improved margins and increased net income, the company is now poised to continue to grow and generate significant value for shareholders.

SmartScoop Outperforms the Competition

Launched in 2007, OurPet’s SmartScoop is a self-scooping litter box solution for cats that has numerous advantages over both traditional cat litter boxes and other automated litter boxes. The product is highly-rated relative to its competition and offers several advantages, including a 6-month supply of waste bags and filters, that give it an edge over others players in the industry.

With an estimated $80 million market for automated litter boxes, the product could bring significant revenues to the company’s top-line and bottom line results in the upcoming quarters.

CosmicPet Acquisition Brings New SKUs

Last year, OurPet’s Company acquired CosmicPet in a move that more than tripled their cat toys and accessories from a mere 50 SKUs to more than 150 SKUs today. The company is now well-positioned in the marketplace as one of the top two leaders focused on the medium price point with catnip toys. Meanwhile, the firm has a pipeline of 75 more SKUs, including trendsetting dog toys and other products.

Based on initial feedback from the introduction of the CosmicPet line, in July of this year, management is optimistic that these products will continue to be well received. These promising initial results should produce significant near-term revenues and long-term market share for the company’s products, as well as pave the way for the additional products coming in the pipeline.

Operational Improvements Boost Bottom Line

OurPet’s is also taking action to enhance its bottom line through operational improvements. For instance, the company’s new ERP system is expected reduce inventories as they bring in new products and thereby improve margins and performance.

With the company’s strategic investments in its infrastructure, management’s long-term goal is to grow at about 20-25% per year on the top-line and bring down 12% of profit before taxes. Looking forward, the company anticipates using its cash flow to pay down its debts related to litigation costs in the past, as well as support its operations and growth.

A Great Investment Opportunity

OurPet’s is a story of tremendous success in a growing, resilient industry. The company is now positioned to unlock significant value for shareholders as it benefits from solid net revenue growth, improved margins and higher profitability.

Growth initiatives pursued during recent years are now contributing to increased performance and further progress is anticipated. It is timely for investors to take a closer look at this unique investment opportunity.

To learn more about OurPet’s Company please see the following resources:

• Company Website
• Latest 10-Q Quarterly Report
• Latest 10-K Annual Report

About Balqon Corporation

Headquartered in Harbor City, California, Balqon Corporation is a leading developer of zero-emissions electric drive systems, lithium battery systems and medium to heavy-duty electric vehicles. Balqon’s proprietary electric drive system encompasses complete power management, propulsion, flux vector motor controllers and energy systems. Balqon electric vehicles and drive systems are marketed globally to companies, governments and municipalities looking for viable and effective ways to reduce their vehicle maintenance and operating costs and lower carbon emissions. Balqon is recognized as a pioneer in commercial electric vehicle technology and development of energy efficient transportation solutions. For more information, please visit www.balqon.com.

At The Heart of Things

Toronto-based Silver Dragon, with global interests in multiple mining properties, has seven of these in China itself, all in the Erbaohuo Silver District of northern China (Inner Mongolia). That positioning not only offsets shipping costs, but naturally offers the likelihood of more favorable treatment by the Chinese government.

The company’s current Chinese mine locations include; Dadi, Laopandao Beihou, Erbahuo, Aobaotugonao, Yuanlinzi Beishuan, Shididonggou, and Zhuanxinhu. These Chinese holdings of Silver Dragon’s are a mix of collaborations with local companies, always a good strategic move for a global company.

According to Silver Dragon’s website, their Erbahuo property “…is scheduled to produce dore silver bars by the third quarter of 2011, which will be sold to smelters for further refining… yielding up to eight (8) tonnes of silver in the first year. Silver Dragon Resources will receive 30% of the net proceeds, before taxes.”  This would represent a significant milestone for the company, as they would become a production mining company with revenues.

The Rise of Silver

Global silver demand and prices tend to ride the coattails of gold. In tough or uncertain times, investors have historically migrated towards these precious metals. But unlike gold- whose principal use is in jewelry- silver has intrinsic value to industry.

According to a U.S. Geological Survey (USGS) report, silver’s uses cover a wide range, including automotive catalytic converters, shoe linings (to reduce odor), photography, electronics, and chemical processes. “Of all the metals, pure silver has the whitest color, the highest optical reflectivity, and the highest thermal and electrical conductivity,” the USGS notes. It’s even used in medical applications for wound care and skin infections, owing to its antibacterial properties.

“The demand for silver in industrial applications continues to increase,” the USGS report goes on, “and includes use of silver in… batteries, brazing and soldering… in cell phone covers to reduce the spread of bacteria… electroplating, hardening bearings, inks, mirrors, solar cells, water purification, and wood treatment to resist mold. Silver [is] used for miniature antennas in Radio Frequency Identification Devices (RFIDs) that were used in casino chips, freeway toll transponders, gasoline speed purchase devices, passports, and on packages to keep track of inventory shipments.”

China has an estimated in-the-ground (ITG) reserve of 43,000 metric tons of silver, compared to only 25,000 metric tons of ITG reserve estimated for the United States. This puts Silver Dragon in an excellent sell-side position as global economies grow.

The irony is that China, as the world’s third-largest silver producer behind Mexico and Peru, since 2007, remains a net importer of the metal to fuel its growing industry. Much of the silver consumed goes into photovoltaic panels, as well as jewelry, according to a May 2011 report issued by CPM Group, a commodities analysis firm.

The CPM Group subscription-only report, Silver Yearbook 2011, was cited by precious metals retailer Kitco as saying that China’s silver output is expected to rise in 2011 to 104.6 million ounces, from 102.7 million ounces in 2010, “driven mainly by production expansions at silver-producing base metal mines.”

CPM also estimated that China’s silver needs for fabrication rose 10.3% in 2010 to 153.3 million ounces, and it expects another 15.6% jump in 2011.

Meanwhile, silver speculators keep watching gold. LiveTradingNews recently said on its website, “the WGC [World Gold Council] said factors such as continued uncertainty over the US economy and the dollar, ongoing European sovereign debt concerns, global inflationary pressures and tensions in the Middle East and North Africa will continue to drive investment demand for gold.” This makes the near-term and medium-term prospects look good for Silver Dragon.  With valuable property in prolific areas in the silver-demand capital of the world, SDRG is poised to  ride the wave of China’s ever-burgeoning economy and industry.

About Balqon Corporation

Headquartered in Harbor City, California, Balqon Corporation (OTCBB: BLQN) a developer and manufacturer of lithium battery powered electric trucks, battery powered energy storage solutions and drive systems for 10 to 50 ton capacity vehicles and material handling equipment. Balqon product line includes 30 ton capacity yard tractors designed to transport containers at ports, warehouses, distribution centers and military facilities. The Company also manufactures complete electric drive systems for electric buses, medium duty trucks and tractors. For more information about Balqon Corporation, visit www.balqon.com.

Electric vehicle market pioneer ZAP (OTC-BB: ZAAP) announced today that it has completed its acquisition of 51 percent of the capital stock of Zhejiang Jonway Automobile Co. Ltd. of Sanmen, Zhejiang, China. Cathaya Capital LP has funded the aggregate amount of US$36 million.

The final payment of US$19 million related to the acquisition was made on January 21, 2011 with the funding from Cathaya Capital. Total cash payment for the acquisition of 51 percent of Jonway Automobile was US$30,030,000.

With ZAP’s electric vehicle (EV) technology expertise and international experience, the combined company intends to build the necessary production platform to address the Chinese EV market. The newly combined company, to be renamed ZAP Jonway, will leverage Jonway Auto’s A380 SUV, as well as its established distribution channels to the Chinese market with over 90 direct dealers. ZAP Jonway will manufacture and sell SUVs powered by ZAP’s electric drive train and expects to benefit from the 60,000 RMB (approximately US$9,000) government incentives granted to electric car buyers.

Jonway Automobile anticipates vehicle sales for its gasoline A380 SUV to increase by 40 percent to over 10,000 vehicles in 2011 compared to 2010. In 2009, its first year of sales, Jonway Automobile experienced sales of 4,000 SUVs, which rose to over 7,000 in 2010, each with a sales price of around US$11,000. ZAP Jonway is currently adding to its manufacturing production lines to deliver the A380 EV SUV by the anticipated date of June 2011 and ZAP’s ALIAS EV roadster by September 2011.

“Jonway Automobile’s revenues from selling its gasoline vehicles will help build the foundation for ZAP Jonway’s growth in the electric vehicle market, allowing ZAP to focus on further strengthening its EV technology, reinforced by Jonway’s manufacturing production expertise and ready market access to China,” said Dr. Priscilla Lu, founder and general partner of Cathaya Capital, a Cross Border Fund focused on China. Dr. Lu has served as Chairman of the Board for ZAP since September 2009. Cathaya Capital has invested US$36 million in ZAP since September 2009 with the goal of completing this 51 percent acquisition of Jonway Automobile.

Jonway Automobile is ISO 9000 certified with over 3.6 million square feet of fully provisioned factory space on 141 acres of land.

This press release contains forward-looking statements. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of ZAP’s products, increased levels of competition, new products and technological changes, ZAP’s dependence upon third-party suppliers, intellectual property rights and other risks detailed from time to time in the ZAP’s periodic reports filed with the Securities and Exchange Commission.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6584291&lang=en

MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6584291

On 1 June 2010 Stealth Energy Inc. (the “Company”) announced that it was implementing a drilling program in its recently acquired Trailblazer property in Montana. The full report on this drilling program is still in progress. However the company is able to announce the following: 22-1 DeJeager, in Rosebud County Montana was drilled to 5102 feet plugged and abandoned, 11-1 Murnion, in Petroleum County Montana was drilled to 2902 feet plugged and abandoned. The results, however, were considered successful in that significant data for the Heath prospect was provided. 7-1 Dexter, in Musselshell County was drilled to 4509 feet and a 5 1/2 inch production casing run to total depth. Currently the company is evaluating two sets of perforations in the Lower Tyler with a view to a “frac” in early 2011.

Robert Gardner Chairman states “This drilling program has been very successful by industry standards and the company is now planning two further drill sites in Musselshell. We look forward with optimism to the “frac” results from the Dexter and future planned drill sites in that County. Thereafter we will further develop in Petroleum County. The Trailblazer property has finally given the company its oil legs for serious company growth”.

The Company has approved the issuance of 4,250,000 incentive options under its stock option plan at an exercise price of 25 cents to its officers, directors, employees, and consultants. This is the third issuance of options under the Stealth stock option plan, making the total options outstanding 6,255,000 and leaving 2,875,800 reserved for future issuance.

Stealth Energy Inc. is a producing oil & gas company with its field office in Billings, Montana, USA. The company develops its own properties and continues to seek and make acquisitions, primarily within Montana and Wyoming. For further information please contact Carlo Nigro at (604) 669-7831 or stealthenergy@telus.net.

Stealth Energy, Inc. (CNSX: SLH) is a Canadian-listed independent oil and gas production company with properties located in Montana and Wyoming. These properties are estimated to contain significant oil and natural gas reserves. As a result, investors may want to pay close attention to this relatively undiscovered investment opportunity.

The company recently announced that it has spud the first of several new wells, each of which could produce significant amounts of oil based on production levels seen in adjacent wells in the area. The firm also has the option to drill several new wells which could create significant near and long-term revenue growth potential.
On September 23, 2010, Stealth Energy announced that road preparation work had been sufficiently completed on the Trailblazer Project site in Rosebud County, Montana, and drilling has commenced. The 22-1 DeJeager well was spud and total depth is expected by end of the week.

With its well just 1,800 feet from a non-company-owned well that had initial production of 342 barrels per day, investors may want to take notice as the firm may be on the cusp of dramatically changing its revenues. Under the terms of its lease agreements, the company has a healthy 87% revenue interest in the wells.

According to a December 24, 2009 report by Peters & Co., a Calgary-based securities firm focused on oil and gas producing companies, the average sale price for oil weighted production during the fourth quarter of 2009 was $100,000 per flowing barrel, which means that valuations among oil companies are also on the rise.

Stealth Energy offers investors a unique opportunity to invest in a relatively undiscovered stock that could soon see significant levels of oil from its new properties. Under even the most conservative valuation metrics, this stock appears to be significantly undervalued.

South Florida-based Capstone Industries, a wholly owned subsidiary of CHDT Corporation (OTC.BB:CHDO), announced its Mini Eco-i-Lite product is now available for the first time at a national office supply chain throughout the holiday season.

The Company has sold its Eco-i-Lite products into grocery, mail order, mass merchandisers, online retailers, specialty retailers, overseas distributors, warehouse clubs and an office supply retailer in 2009. The Mini Eco-i-Lite has gained much popularity over the past year. It is Capstone’s smaller version of the Eco-i-Lite series featuring a lithium-powered, multi-function, power failure light. The device includes 3 LED bulbs, an LED nightlight and an induction-charging ring. The unit is environmentally friendly and requires no battery or bulb change making the light affordable to own. The product automatically illuminates when lifted from its charging ring or when a power failure occurs and provides soft nighttime lighting to help users find their way in the dark.

Not only does the Eco-i-Lite provide multiple lighting functions, it is also stylish and pleasing to the eye, eliminating the need to hide it in a drawer or utility area. The Eco-i-Lite’s aesthetic appeal makes it easy for the homeowner to place it anywhere in the home. Once in plain sight, the Eco-i-Lite remains charged and ready for use when needed.

For more information about the Eco-i-Lite product line, including a list of current retailers, please visit Capstone Industries’ website at www.capstoneindustries.com.

About Capstone Industries, Inc.

For more than a decade, the South Florida-based Company Capstone Industries has specialized in the design, production, and distribution of consumer products as a supplier to major retail operations throughout the USA. Capstone Industries is committed to the development and distribution of unique and inventive products to a variety of channels including bookstore chains, convenience stores, drug & grocery, electronics, hardware, home improvement, internet, mail order, mass market, office supply, specialty, and warehouse clubs.

About CHDT Corporation

CHDT Corporation (www.chdtcorp.com) is a public holding Company that engages, through its wholly owned subsidiaries, in the development, manufacturing, logistics, and distribution of consumer products to retailers and wholesalers throughout North America. See www.chdtcorp.com for more information about the Company and also www.capstoneindustries.com for information on our current product offerings. Reference of URLs in this press release does not incorporate said URLs or any of their contents in this press release.

FORWARD-LOOKING STATEMENTS: This press release, including the financial information that follows, contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995, as amended. These statements are based on the Company’s and its subsidiaries’ current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. CHDT undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements in this press release and risks associated with any investment in CHDT, which is a small business concern and a “penny stock Company” and, as such, a highly risky investment suitable for only those who can afford to lose such investment, should be evaluated together with the many uncertainties that affect CHDT’s business, particularly those mentioned in the cautionary statements in current and future CHDT’s SEC Filings.

Neonode, Inc. (OTC-BB: NEON) provides optical touchscreen solutions for handheld consumer and industrial electronic devices. Recently, the company has seen exceptional interest and trading volume after announcing that Sony’s new line of e-book readers contain its optical touchscreen technology that has been customized for the consumer electronics company.

According to the company, the cost of its revolutionary zForce touchscreen solution is roughly the same as a primitive resistive touch screen solution – similar to the ones used on old Palm Pilots – and 65% lower than the cost of capacitive touchscreen solutions – such as those on modern iPhones. Given its advanced feature set and low cost, it is little wonder that many companies are considering the switch.

Neonode’s deal with Sony serves as a key validation of its technology in mainstream applications, which could pave the way for other companies to follow in its footsteps. While some companies like Apple are already set in their ways, large scale original equipment manufacturers (OEMs) and other overseas producers that compete largely on price are expressing interest.

On December 29, 2009, the company signed a deal with one such OEM to provide services over a three-month period in 2010 related to the development of a touchscreen application for their mobile phone product. Meanwhile, the firm signed two additional technology license agreements with global OEMs in July and they are in discussions with two others as of June 30, 2010.

As more and more consumer electronics companies evaluate the superior features and lower cost that zForce offers, Neonode is likely to see significantly higher bookings over the coming quarters and years. And with the releases of Apple’s iPad and touch screen interfaces for new mobile phones, the trend isn’t about to slow down anytime soon. Combined, these factors make NEON a stock worth considering!

ImmunoCellular Therapeutics Ltd. (OTC-BB: IMUC) is a $20 million company developing its own cancer drug based upon the same premise as Dendreon’s Provenge. But unlike its larger competitor, IMUC is focused on a number of different antigens rather than just one. And unlike other development-stage companies, it has a strong focus on cost-containment and building long-term shareholder value.

Run by a former venture capitalist who left his career to pursue this opportunity, ImmunoCellular is a unique “diamond in the rough” in the often-troublesome OTC-BB marketplace, with both a promising cancer treatment drug and a cash stockpile to see it through development.

A Promising Cancer Drug in Development

ImmunoCellular’s ICT-107 is a novel immune-based dendritic cell cancer therapy that targets six glioma-specific peptides several of which are highly expressed on cancer stem cells. Since the unique approach targets multiple antigens, instead of just one like Dendreon’s Provenge, the company believes that the drug will prove far more effective and versatile in treating a number of different types of cancer.

During the industry’s flagship ASCO Conference in June, IMUC unveiled the results of its 20-patient Phase I study for ICT-107. The clinical trials demonstrated a 100% survival rate in one year and an 80% survival rate in two years, compared to a historical 61% survival rate in one year and 27% survival rate in two years, observed in the standard treatment. This data compares favorably with Avastin (Roche: RHHBY) and CDX-110 (Celldex:CLDX) as only ICT-107 has demonstrated greater than 75% survival at 2 years which is quite unheard of in glioblastoma.

Meanwhile, the safety data also compared favorably to the current treatments with no serious adverse effects reported, and only minor side-effects related to fatigue, skin rash and pruritis. As a result, the company’s ICT-107 appears to be a promising potential treatment for a number of cancers with limited or no treatment options, including the Phase I study candidate, brain cancer.

Currently, the company is designing a well powered Phase II study to better determine the efficacy of its treatment. But if Phase I results are any indication, investors may want to get in this stock early to take advantage of the large run-up that any successful clinical trials would bring. After all, even half of the efficacy seen in previous trials would have far reaching potential for patients and investors.

A Lean Company with Cash and Prospects

Unlike many development-stage companies, ImmunoCellular also has a healthy $8 million in cash that it believes will fund its clinical trials well into Phase II, where it will likely seek a commercialization partner in order to contain costs and maintain shareholder value. As a result, investors have less risk of dilution or excessive debt being taken on than in some other names like Genta Incorporated (GETA).

IMUC is also working on developing other cancer therapeutic and diagnostic products, such as ICT-69 and ICT-121. The company recently entered a research and license option agreement with Roche (RHHBY) for up to $32 million in milestone and development payments for its ICT-69 drug, while the Phase I study of its ICT-121 drug is expected to yield results in mid to late 2011.

In the end, investors looking for the next Dendreon (DNDN) may want to consider taking a closer look at ImmunoCellular (IMUC) as a potential investment. While clinical trial results aren’t expected in the near-term, the firm has a number of catalysts that could drive the stock higher and maintains a pristine balance sheet that minimizes risk of dilution of shareholder-unfriendly actions.

EcoloCap Solutions, Inc. (ECOS) announced earlier this week that they signed an agreement with Exponent Engineering and Scientific Consulting of Phoenix, AZ to test its newly announced and very promising Lithium X batteries. Many investors are looking forward to the completion of these tests, as they represent one of the last barriers before its products can go to market.

Preliminary indications from independent and prospective customer labs over the last month indicated that Li-X is the highest power density output battery per weight of any commercial battery in the market, according to President and CEO Michael Siegel. The new batteries also have greater thermal efficiency and a longer lifecycle than existing lead or lithium batteries.

Quality Testing from a Reputable Company

With a staff of over 900 scientists and engineers, Exponent is uniquely qualified to conduct in-depth testing to officially confirm the Lithium X battery’s performance versus competing batteries in the marketplace. By using a multidisciplinary approach involving staff from a wide range of disciplines, the firm’s testing is unparalleled in quality.

The state-of-the-art laboratories at Exponent utilize Maccor battery testers, Gamry electrochemical analysis instruments, and a TIAX accelerated rate calorimeter. Its facilities include provisions for full environmental control including an argon-filled glove box, temperature, humidity and pressure control chambers, salt spray, and burn pads for destructive abuse testing.

In fact, Exponent’s quality management system is independently assessed against the most recognized and comprehensive international standard for quality management systems, ISO 9001, demonstrating its extensive abilities to test and certify products. Verification of this certification can be found on their web site: http://www.exponent.com/files/Uploads/Documents/Exponent_9001cert_expires2010oct.pdf.

Exponent can also perform testing described in the United Nations Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, for lithium and lithium-ion batteries, known as the UN T Test.
Commercial Entry into the $50 Billion Battery Market

EcoloCap has stated that it will publish side-by-side comparisons and results as soon as they are made available. Once published, the testing results should provide the groundwork for the company to begin selling its products into the $50 billion U.S. battery markets.

Since the company already has distributors in both the U.S. and abroad lined up, investors could see these test results as a near-term catalyst for explosive growth in 2010 and beyond.

EcoloCap Solutions, Inc. (OTC-BB: ECOS) could be ready to make the jump from development-stage to profitable enterprise in 2010, with its revolutionary portfolio of nanotechnology-enhanced alternative energy products and related services. The company is uniquely positioned in three distinct markets with substantial progress being made on all fronts.

THE $30+ BILLION BATTERY MARKET

Using advanced Nano Technology, and wrapping the cathode and anode terminals of traditional lead acid batteries with carbon nanotubes, EcoloCap has produced a modified battery with 8x the reserve capacity of an unmodified lead acid battery and 99.9% recyclability. These batteries appear far superior to any others currently in the market, including lithium-ion batteries produced by companies like A123 Systems, Inc. (AONE).

Highlights:

• Eight times the reserve capacity of the unmodified battery.
• Three times the energy density of regular lithium-ion batteries.
• 99.9% recyclability to keep the environment clean.
• Recharge time of just 5 to 10 minutes.
• 10x+ improved battery lifetime.
• Roughly the same cost as the unmodified battery.

THE ECOLOCAP LITHIUM X BATTERY

EcoloCap’s newly introduced Lithium – X battery is the highest density output battery per weight of any commercial battery available today. No other battery on the market compares with EcoLocap’s Li-X battery. The Li-X is only 1/5 in weight and 1/7 in measurement comparing with lead acid batteries. The thermal efficiency of the Li-X battery (over 98), under charge and discharge, is greater than any existing battery.

Learn More:

• EcoloCap Introduces Lithium X Battery
• EcoloCap Announces First Delivery of CNT-Battery
• EcoloCap Releases CNT-Battery Preliminary Comparative Testing Results
• MBT Signs Second Multi-Million Dollar Agreement for Distribution Rights of Its CNT-Battery

THE $20+ BILLION HEAVY FUEL MARKET

By combining oil, water, and a proprietary additive and processing in a patented Nanomizer machine, EcoloCap can generate a new fuel that costs up to 25% less than traditional fuels, while reducing emission by 60%! The company has also already shipped its first units to potential customers around the world, which creates potential for widespread adoption in the marketplace.

Highlights:

• Reduced emissions by 60% or more.
• Reduced cost by up to 25% compared to the unmodified fuel.
• Can be used in un-modified engines.
• Reduced fuel consumption by 40% (replaced by water).
• Tested for two years in marine environments and labs.

Learn More:

• EcoloCap Announces the First Shipments of M-Fuel
• EcoloCap Analyzes M-Fuel Users Carbon Credit Earning Potential

THE $60 BILLION CARBON CREDITS MARKET

Through innovative environmental solutions in emerging markets, EcoloCap has developed a strong portfolio of CDM projects that will generate a substantial amount of marketable carbon credits.

Highlights:

• Turn-key solutions for the carbon credit market place.
• Strong network that guarantees a continuous flow of projects.
• Large addressable market in its infancy.
• Partnered with Gazprom the world’s largest gas producer!

In a first transaction, Gazprom Marketing and Trading and EcoloCap Canada Ltd. have entered into a contract for the development of nine Carbon Credits producing projects  in Vietnam that are estimated to generate 500,000 CERs (Carbon Credits) yearly. At the present world market price, the transaction represents a yearly value of approximately USD$8,500,000.

Dr Tri Vu Truong, President and CEO of EcoloCap Canada stated: “We are very proud to be associated with Gazprom Marketing and Trading, a wholly-owned subsidiary of the Gazprom Group, the world largest gas producer. For the benefit of our customers this partnership will be a key element assuring the success for the development of their projects as Gazprom represents extensive international experience as well as unquestioned financial strength. In this perspective we are looking forward to developing an increasing number of others projects to be materialized in the near future.”

Gazprom Group

Gazprom is one of the world’s largest energy companies..

Gazprom Group possesses the world’s largest natural gas reserves. As of December 31, 2008 the Group’s A+B+C1 resources were estimated at 33.1 trillion cubic meters. According to the international PRMS standards the Group’s proven and probable hydrocarbon reserves are estimated at 27.3 billion tons of fuel equivalent and valued at USD 230.1 billion.

With 17 per cent of the global gas production, Gazprom Group is the leader among the world’s oil and gas companies. In 2008 Gazprom Group produced 549.7 billion cubic meters of gas.

Learn More:

• Ecolocap Solutions Announces Partnership with Gazprom

M-Fuel and the Marine Industry

EcoloCap Solutions is in an advantageous position to generate contracts for their revolutionary M-Fuel.  For example, a ship that leaves Incheon, South Korea to Los Angeles, CA can realize a 40% savings on its fuel costs, while generating more than thousands of carbon credits that can be resold at a current market price of approximately 14 euros.

EcoloCap enables the $20+ billion dollar heavy fuel market to protect the environment, while saving money on fuel costs and while generating valuable carbon credits.

A High-Quality Management Team

Michael Siegel

Mr. Siegel is the CEO of EcoloCap Solutions Inc. and the President of Micro Bubble Technologies Inc., and is responsible for the overall development of both companies.  He brings to the business more than thirty years of experience and leadership from his tenure in the technology industry.

After studying for a B.A. in Electrical Engineering, he joined the Marine Corps where he earned a number of engineering certifications. Since his discharge, he has been involved with, developed, and sold numerous technology related enterprises worldwide.

Tri-Vu Truong Ph.D.

Chief Executive Officer, EcoloCap Solutions Inc. Canada Dr. Truong is the CEO of EcoloCap Solutions Inc. Canada and is responsible for the operations of the business. He brings more than thirty years of experience from his tenure in the environmental sector.

Upon completion of his B.S. in Engineering, he then earned an M.S. in Chemical Engineering, and later a Ph.D. in Civil Engineering. He has since joined Sodexen Environmental Engineering Group, where he managed numerous major environmental impact projects.

Robert Egger, Jr.

Mr. Egger is the COO of EcoloCap Solutions Inc and the CEO of Micro Bubble Technologies Inc., and is responsible for the overall management of both companies.  He brings more than thirty years of experience from his career in the engineering and technology industries.

Upon completion of his B.A. in Network Engineering, he joined the Army where he achieved numerous certifications in computer related fields.  After several years of service he joined the Network Operations Team at Qwest Communications where he served as the Mid-West’s Regional Manager of Network Operations.

In the end, EcoloCap has a number of near-term catalysts as it works to commercialize its revolutionary product line, which could make now an opportune time to get involved with the stock for those looking for a high-risk, high-reward alternative energy play. Investors that wish to talk to management and learn more should call 888-288-5215.

EcoloCap Solutions Inc. (ECOS) today announced that its wholly-owned subsidiary EcoloCap Canada Ltd, has signed a partnership agreement with Gazprom Marketing and Trading, for the development of CDM Projects in Asia.

In a first transaction resulting from this agreement, Gazprom Marketing and Trading and EcoloCap Canada Ltd. have entered into a contract for the purchase of Carbon Credits (CER of nine renewable projects in Vietnam that is estimated to generate 500,000 CERs yearly). At the present world market price, the transaction represents a yearly value of some 8,500,000 US.

Dr Tri Vu Truong, President and CEO of EcoloCap Canada stated: “We are very proud to be associated with Gazprom Marketing and Trading, a wholly-owned subsidiary of the Gazprom Group, the world largest gas producer. For the benefit of our customers this partnership will be a key element assuring the success for the development of their projects as Gazprom represents extensive international experience as well as unquestioned financial strength. In this perspective we are looking forward to developing an increasing number of others projects to be materialized in the near future.”

Michael Siegel, President and CEO of EcoloCap Solutions Inc. stated: “Dr Truong is a worldwide respected expert in the environmental field and we consider ourselves privileged to have him on our team. This agreement with a world leading company is proof of the credibility he has in the market. We are looking forward to working with Dr Truong on our M-Fuel projects where our clients can benefit greatly from the generation of Carbon Credits through the use of M-Fuel. ”

About The Company: EcoloCap Solutions Inc. (OTC.BB:ECOS – News) and its subsidiaries Micro Bubble Technologies Inc. (“MBT”), K-MBT Inc. of Seoul Korea and EcoloCap Solutions Canada Inc. of Montreal, are an integrated network of environmentally focused technology companies that mainly utilize nanotechnology to develop efficient alternative energy solutions. Their portfolio of products and services include MBT’s Carbon Nano Tube (CNT) and Lithium X rechargeable batteries that surpass the performance of batteries in the market today, MBT’s M-Fuel, a breakthrough suspension fuel for diesel and heavy oil applications that greatly reduces cost and the emission of harmful gases, and EcoloCap Solutions Canada Inc. which offers Carbon Credit UN Certification and trading services. For additional information, please visit the EcoloCap website, http://www.EcoloCap.com.

This press release may contain statements of a forward-looking nature regarding future events. These statements are only predictions and actual events may differ materially. Please refer to documents that EcoloCap Solutions Inc. files from time to time with the Securities and Exchange Commission for a discussion of certain factors that could cause actual results to differ materials from those contained in the forward-looking statements.

Sinobiopharma, Inc. (SNBP) is pleased to announce that its production facility for solid dosage Perindopril has passed the required Chinese State Food and Drug Administration (SFDA) inspection and is now approved for production and marketing.

Sinobiopharma had received SFDA approval for its formulation of Perindopril, the first version of the drug to be developed in China, in April 2009.  SFDA regulations require that drug makers conduct large-scale production of at least three batches of a newly approved drug in a Good Manufacturing Practice (GMP) certified production facility. SFDA officials inspect the production process, the application of GMP standards, and conducted a full test of randomly picked samples of the drug. Sinobiopharma successfully met all the requirements and now has received approval to distribute the drug throughout China.

The Company believes its formulation of Perindopril is the latest generation worldwide of the product, which is part of a class of medications known as angiotensin-converting enzyme (ACE) inhibitors. These medications are used alone or in combination with other medications to treat high blood pressure.  Perindopril allows blood to flow more smoothly by preventing the production of certain natural chemicals that constrict blood vessels.  Every year, US$3.7 billion is spent on the treatment of hypertension in China.  Sinibiopharma’s Perindopril will be marketed under the trade name YiTai in China.

“We believe that YiTai is a first-to-market drug in China and therefore enjoys the benefit of having a government sanctioned price premium as well as certain exclusive marketing rights to hospitals,” said Dr. Lequn Lee Huang, CEO of the Company. “The market for anti-hypertensives in China is huge, but highly fragmented. Sinobiopharma’s YiTai is well positioned to capture substantial market share quickly.”

About Sinobiopharma

Sinobiopharma, Inc. is a fully integrated and highly innovative specialty biopharmaceutical company engaged in the research and development, manufacture and marketing of biopharmaceutical products in China, one of the world’s fastest growing pharmaceutical markets. Known as Dong Ying (Jiangsu) Pharmaceutical Co., Ltd. in China, the Company’s current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs.

FORWARD LOOKING STATEMENTS

This news release may include “forward-looking statements” regarding Sinobiopharma, Inc., and its subsidiaries, business and project plans. Such forward looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where Sinobiopharma, Inc. expresses or implies an expectation or belief as to future events or results, such expectation or belief is believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Sinobiopharma, Inc. does not undertake any obligation to update any forward looking statement, except as required under applicable law.

The company has delivered the first CNT Batteries to the United States for independent testing and analysis. Once the brief independent testing is completed, the company will quickly move forward with its planned market and production program.

After years of development, EcoloCap (ECOS) has delivered the first Carbon Nano Tube Technology battery for independent testing in the U.S. Once the tests completed the company will move forward with its planned marketing and production program.

EcoloCap Solutions Inc. (ECOS), an innovator of alternative energy products, today announced that the first shipment of its CNT-Battery Technology has been delivered from its Korean facility to the Company’s US headquarters for independent testing. The battery will be tested for all technical aspects, including reserve capacity, cell voltage, thermal efficiency and charge time. Results will be published as soon as available.

Michael Siegel, President and CEO of EcoloCap Solutions and its subsidiary Micro Bubble Technology, stated: “It has been a long road to get us to this point. Our scientists have come up with results worthy of all the attention the product has attracted worldwide in the last six months. We are looking forward to publishing test results that will confirm the advance billing of that new technology and put to rest all questions on the product”.

The CNT Battery was developed by K-MBT Inc., the Company’s Seoul, Korea subsidiary. EcoloCap’s line of 12 volt CNT-Battery, constructed with advanced Carbon Nano Tube technology, offers significantly enhanced performance characteristics and lower operating costs for a variety of industrial and automotive applications.

Mr. Siegel also announced that the Company is completing the development of a next generation Nano Lithium battery. More specific information about this technology and its performance characteristics will be made available shortly.
Further information on EcoloCap’s CNT Batteries can be found at http://www.ecolocap.com/site/en/mbt-cnt-battery.html

About The Company: EcoloCap Solutions Inc. (OTC.BB:ECOS – News) and its subsidiaries Micro Bubble Technologies Inc. (“MBT”), K-MBT Inc., and EcoloCap Solutions Canada Inc. are an integrated group of environmentally focused technology companies that utilize advanced nanotechnology to design, develop, manufacture and sell alternative energy products. Their portfolio of products and services include MBT’s Carbon Nano Tube Battery (CNT-Battery), a rechargeable battery that surpasses the performance capabilities of any existing battery, MBT’s M-Fuel, an innovative suspension fuel for non-gasoline applications that exceeds all conventional fuel’s efficiency, and EcoloCap Solutions Canada Inc. a comprehensive Carbon Credit Trading and Certification consultancy service. EcoloCap markets its products worldwide, directly and through agreements with distributors. For additional information, please visit the EcoloCap website, http://www.EcoloCap.com.

This press release may contain statements of a forward-looking nature regarding future events. These statements are only predictions and actual events may differ materially. Please refer to documents that EcoloCap Solutions Inc. files from time to time with the Securities and Exchange Commission for a discussion of certain factors that could cause actual results to differ materials from those contained in the forward-looking statements.

Sinobiopharma Inc. (SNBP), a manufacturer and marketer of biopharmaceutical products in China, announced earnings of $1,073,550 for the three months ended November 30, 2009, compared to a net loss of $1,045,239 during the same period a year ago.

Revenues increased 120% to $2,137,471 and gross margins that improved 182% to 80% of sales, both of which were attributed to continuing growth in the sales of Cisatracurium Besylate. The drug now represents approximately 96% of the company’s total sales.

Operating expenses decreased 63% to $596,154 due to a decrease in stock-based compensation and a reduction in general and administrative expenses. However, research and development expenses rose to $189,396 from $33,015 a year ago.

As a result, net cash from operating activities rose $804,518 to $1,124,109 compared to $319,591 for the six months ended November 30, 2008 versus November 30, 2009.

Notably, Sinobiopharma is also actively enhancing internal controls in order to improve reporting standards. In October 2009, the company engaged Xinjie Mu, a certified public accountant with extensive experience in internal control and U.S. GAAP reporting compliance, as Chief Financial Officer. These efforts should help increase investor confidence.

About Sinobiopharma

Sinobiopharma, through its operating subsidiary Dong Ying China, is involved in the Chinese biopharmaceutical industry. The company has developed new methods for synthesis of active pharmaceutical ingredient (“API”) and innovative drug delivery (new formulation) that dramatically reduces the time and cost of drug development.

The company’s current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs. And it’s R&D focus is new, innovative methods of synthesizing compounds more rapidly at lower cost, and/or improved drug formulation with enhanced usability.

In November 2009, the company received final approval from all authorities for the production and sales of our new drug Perindopril with brand name of Yitai. Yitai is a cardiovascular drug used for the patients with heart disease and high blood pressure, and it is covered by Chinese health insurance.

Provectus Pharmaceuticals, Inc. (PVCT), which is developing a revolutionary cancer drug called PV-10 based on the Rose Bengal staining compound, updated shareholders in a letter issued on January 7, 2010. In the letter, management outlined its 2010 development plans and expressed enthusiasm as it prepares for some very important events this year.

A Successful 2009 Lined with Milestones

In 2009, Provectus reached many milestones in the development of PV-10 for metastatic melanoma. The company completed subject accrual in its Phase 2 trial and presented interim data for the study at the 2009 American Society of Clinical Oncology (ASCO) Scientific Proram in May and June.

The abstract that Provectus presented reported that initial one year overall survival data from the first 20 subjects in the current Phase 2 trial showed comparable trends to those of the Phase 1 trial, which were markedly longer overall and disease specific survival for subjects that were responsive to PV-10 relative to those who did not experience a robust response.

Meanwhile, based on requests from physicians, Provectus initiated two expanded access programs (“compassionate use”) for PV-10 in Australia and the U.S. These are active at five of the company’s Phase 2 study centers, with a total of 20 melanoma patients and 8 of those who have crossed over from the Phase 2 study for additional treatment.

Looking Ahead to 2010 and Beyond

Provectus has ample cash on its balance sheet to fund their development activities through the end of 2010, with an estimated $300,000 needed to complete current clinical trials. The company intends to push aggressively ahead with its PV-10 development by collecting and analyzing final data from all 80 of its trial subjects and providing shareholders with updates.

The potential success of PV-10 has huge implications for Provectus and cancer patients around the world. According to the American Cancer Society, there were approximately 62,000 new cases of melanoma in the U.S. in 2008, leading to more than 8,000 deaths. Meanwhile, the World Health Organization estimates that 48,000 patients globally die from the disease.

In the end, Provectus shareholders have a lot of positive developments in 2010. Additional interim results from its Phase 2 trials, and its compassionate use program results represent substantial catalysts for the stock price.

View Provectus Pharmaceuticals’ full Shareholder Report by visiting the following link:
http://www.pvct.com/pressrelease.html?article=20100107

Provectus Pharmaceuticals, Inc. (PVCT), which specializes in developing oncology and dermatology therapies, is developing a treatment designed to more effectively combat cancer while lessening the harmful side-effects seen in other treatments like chemotherapy. The treatment is largely based on a staining compound known as Rose Bengal.

Provectus discovered a novel use for Rose Bengal – a small molecule agent with an established safety history and a short half-life in the bloodstream – based on the observation that it is selectively toxic to cancer cells via a process called chemoablation whereby cells undergo a form of cell death that mimics both features of necrosis and apoptosis.

The American Cancer Society estimates that there are 120,000 Americans diagnosed with Stage III or Stage IV melanoma, and 68,000 more new cases will be diagnosed in 2009. On a global scale, the World Health Organization estimates that 48,000 people died of Stage III and Stage IV melanoma in 2008.

Clinical Trials Show Safety and Efficacy

Provectus announced updates to its Phase I trial data back in November 2009 and found that its PV-10 demonstrated the drug’s safety in patients using it over a one-year period. Moreover, PV-10 also showed markedly longer overall and disease specific survival for subjects that were responsive to the drug relative to those who did not experience a robust response.

Subsequently, Provectus presented early results from its Phase II trial during the annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida in June 2009. Researchers found that an objective response was observed in 60% of subjects and locoregional disease control of treated lesions was observed in 75% of subjects.

Provectus also observed a so-called “bystander effect” whereby untreated bystander lesions also responded to the treatment. The company believes that this could be because the drug induced the patient’s own immune system to attack and shrink untreated tumors. This would be of enormous benefit given that some cancers spread to difficult-to-treat areas like the neck.

Strong Near-term Catalysts…

Full follow-up data from the  first 40 subjects in its Phase II study is expected to become available in the first quarter of 2010, while the company prepares for its Phase III trials to begin, if necessary since it is pursuing accelerated approval.

Meanwhile, the company has also expanded its access program for PV-10 through compassionate use for qualified patients. Combined, this data could go a long way in attracting a potential partner and/or moving forward with anticipated approval of the drug.